Cite

HARVARD Citation

    Potena, L. et al. (2018). Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients. Transplantation. 102 (3), p. . [Online]. 
  
Back to record